Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients

Journal of Thoracic Oncology

Volumn 6, Issue 9, 2011, Pages 1460-1467

  Takahashi, Yusuke ^a,b   Ishii, Genichiro ^a   Taira, Tetsuhiko ^a   Fujii, Satoshi ^a   Yanagi, Shinya ^a   Hishida, Tomoyuki ^a   Yoshida, Junji ^a   Nishimura, Mitsuyo ^a   Nomori, Hiroaki ^b   Nagai, Kanji ^a   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Epithelial mesenchymal transition; Fibrous stroma; Prognostic indicator; Squamous cell carcinoma; Vascular invasion

Indexed keywords

LAMININ; LAMININ 5GAMMA2; MATRILYSIN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; STROMA;

EID: 80052230639     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318229189d     Document Type: Article

References (30)

1. Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell 2002;1:49-52. (Pubitemid 41039175)
2. Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry study: Prognosis of 13,010 resected lung cancers. J Thorac Oncol 2008;3:46-52.
3. Cardone A, Tolino A, Zarcone R, et al. Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer. Panminerva Med 1997;39:174-177. (Pubitemid 127520544)
4. Maeshima AM, Niki T, Maeshima A, et al. Modified scar grade: A prognostic indicator in small peripheral lung adenocarcinoma. Cancer 2002;95:2546-2554. (Pubitemid 35424041)
5. Olumi AF, Grossfeld GD, Hayward SW, et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999;59:5002-5011. (Pubitemid 29472907)
6. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005;121:335-348. (Pubitemid 40692295)
7. Parmar H, Cunha GR. Epithelial-stromal interactions in the mouse and human mammary gland in vivo. Endocr Relat Cancer 2004;11:437-458. (Pubitemid 39331276)
8. Kawase A, Ishii G, Nagai K, et al. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int J Cancer 2008;123:1053-1059.
9. Nakao M, Ishii G, Nagai K, et al. Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma. Cancer 2009;115:2732-2743.
10. Travis WD, Brambilla E, Mueller-Hermelink HK, et al. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press, 2004.
11. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706-714. (Pubitemid 47357522)
12. Funai K, Yokose T, Ishii G, et al. Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung. Am J Surg Pathol 2003;27:978-984. (Pubitemid 36758901)
13. Aokage K, Ishii G, Ohtaki Y, et al. Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal- epithelial transition in the early phase of metastatic tumor formation. Int J Cancer 2011;128:1585-1595.
14. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-337. (Pubitemid 39551661)
15. Mueller MM, Fusenig NE. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004;4:839-849. (Pubitemid 39472951)
16. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-273.
17. Hanrahan EO, Lin HY, Kim ES, et al. Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol 2010;28:193-201.
18. Rajski M, Zanetti-Dallenbach R, Vogel B, et al. IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients. BMC Med 2010;8:1.
19. Iwatsuki M, Mimori K, Yokobori T, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 2010;101:293-299.
20. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999; 24:73-76. (Pubitemid 29346577)
21. Schenk S, Hintermann E, Bilban M, et al. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 2003;161:197-209. (Pubitemid 36459091)
22. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-174. (Pubitemid 37328786)
23. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009;119:1429-1437.
24. Soltermann A, Tischler V, Arbogast S, et al. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 2008;14: 7430-7437.
25. Zhang X, Yang J, Li Y, et al. Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells. Am J Physiol Renal Physiol 2005;288:F16-F26. (Pubitemid 40038672)
26. Grugan KD, Miller CG, Yao Y, et al. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc Natl Acad Sci USA 2010;107:11026-11031.
27. Ueno H, Murphy J, Jass JR, et al. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40:127-132. (Pubitemid 34122114)
28. Shimizu Y, Yamamichi N, Saitoh K, et al. Kinetics of v-src-induced epithelial-mesenchymal transition in developing glandular stomach. Oncogene 2003;22:884-893. (Pubitemid 36255824)
29. Shinto E, Jass JR, Tsuda H, et al. Differential prognostic significance of morphologic invasive markers in colorectal cancer: Tumor budding and cytoplasmic podia. Dis Colon Rectum 2006;49:1422-1430. (Pubitemid 44401393)
30. Yamaguchi Y, Ishii G, Kojima M, et al. Histopathologic features of the tumor budding in adenocarcinoma of the lung: Tumor budding as an index to predict the potential aggressiveness. J Thorac Oncol 2010;5: 1361-1368.